Search Results
52 items found for "Jonathan F Fay"
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
MRGPRD GPCR Chunyu Wang , Yongfeng Liu , Marion Lanier , Brian K Shoichet , Esther Martinborough , Jonathan F Fay , Can Cao , Bryan L Roth , et al.
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
September 2022 "The Smoothened receptor (SMO, a 7 pass transmembrane domain, Class F GPCR family protein
- GPCR/endocytosis/ERK signaling/S2R is involved in the regulation of the internalization...
We recently have shown that fluorescently labeled Hst1 (F-Hst1) targets and activates mitochondria, presenting We also adopted live cell imaging to monitor the whole intracellular trafficking process of F-Hst1. Our results showed that the inhibition of cellular respiration hindered the internalization of F-Hst1 significantly reduced the uptake, which was accompanied by the nullification of the promoting effect of F-Hst1 We further showed the intracellular trafficking and targeting process of F-Hst1, in which early endosome
- Unconventional GPCR-PKA Communication in the Hedgehog Pathway
Learn about communication between GPCRs and PKA, Class F GPCR Smoothened & the Hedgehog signaling pathway
- Production of human A2AAR in lipid nanodiscs for 19F-NMR and single-molecule fluorescence...
August 2022 Production of human A 2A AR in lipid nanodiscs for 19 F-NMR and single-molecule fluorescence
- Dr. Ben Myers - Dr. GPCR Podcast
From studying sensory #ionchannels to the group leader at the University of Utah investigating Class F
- 📰 GPCR Weekly News, March 18 to 24, 2024
AlphaFold2 predicted water-soluble QTY variants and uncovering the natural mutations of L->Q, I->T, F- >Y and Q->L, T->I and Y->F Industry News Sosei Heptares Doses First Subject in Phase 1 Trial with HTL0033744
- All Aboard the GPCR Express: Your Weekly Update is here! Oct 14-20, 2024
Schulte for his excellent work on International Union of Basic and Clinical Pharmacology CXV: The Class F CXCR1 Reviews, GPCRs, and more International Union of Basic and Clinical Pharmacology CXV: The Class F
- 📰 GPCR Weekly News, July 1 to 7, 2024
CXV: The Class F of G Protein-Coupled Receptors Yusman Manchanda , Dr. metabolic diseases: pharmacotherapeutic development updates Targeting G protein-coupled receptors for heart failure CXV: The Class F of G Protein-Coupled Receptors Structural and Molecular Insights into GPCR Function
- Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
into six classes based on amino acid sequence similarities, but only four of the classes (A, B, C, and F)
- VAMP2: a crucial player in the delivery of MOR to the synapse
., F. Deak, A. K ´ onigstorfer, M. Mozhayeva, Y. Sara, T.C. Südhof, and ¨ E.T. Kavalali. 2001. Wang, F., X. Chen, X. Zhang, and L. Ma. 2008.
- Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused...
ranges, (e) acute exacerbations could be successfully treated with prednisolone and/or calcimimetics, (f)
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
levels and leads to a decrease in the area and compaction of amyloid plaques in the preclinical AppNL-G-F
- Genome-wide identification of 216 G protein-coupled receptor (GPCR) genes from the marine water ...
water flea Diaphanosoma celebensis genome, which were classified into five distinct classes (A, B, C, F,
- Dr. GPCR University registration is now open! Secure your spot now!
Signal Transduction Pathways Activation of a GPCR, ORL1 receptor: A novel therapy to prevent heart failure treatment GPCRs in Neuroscience Astrocytes control quiescent NSC reactivation via GPCR signaling-mediated F-actin
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
., Rodríguez De Fonseca, F., Puente, N., Marsicano, G., & Grandes, P. (2016). M., & Murray, F. (2018).
- Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair
October 2022 "Systolic heart failure (HF) is a chronic clinical syndrome characterized by the reduction salient alterations that confer significant hormonal burden on the already compromised function of the failing mineralocorticoid receptor antagonists, which block the effects of angiotensin II (AngII) and aldosterone on the failing almost all aldosterone, of all epinephrine, and of a significant amount of norepinephrine reaching the failing
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
www.ecosystem.drgpcr.com/post/decoding-gpcr-function-the-role-of-mutagenesis-in-rational-drug-discovery Heydenreich, F.
- Decoding β-Arrestins: from Structure to function
F et al. 2021, Chen, H. et al. 2022). F. et al. 2021).
- From DNA day to GPCR genomics
., He, F., Maul, L., Gmeiner, P., Kobilka, B. K., Hildebrand, P. W., & Skiniotis, G. (2023).
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
Heydenreich, F. M., Marti-Solano, M., Sandhu, M., Kobilka, B. K., Bouvier, M., & Babu, M.
- Nanobodies: New Dimensions in GPCR Signaling Research
., Thian, F. S., Kobilka, T. S., Schnapp, A., Konetzki, I., Sunahara, R. K., Gellman, S.
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
detecting endogenous GPCR activity in primary cell cultures using ONE-GO biosensors Quantitation of F-actin
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
., Heydenreich, F. M., Kawakami, K., Masureel, M., Maeda, S., Garcia, K.
- Overview of adhesion GPCRs self-activation
aGPCR family was performed highlighted a new hydrophobic conserved motif composed of phenylalanine (F)
- GRK2 in cardiovascular disease and its potential as a therapeutic target
Despite major advances in the field of pharmacological CVD treatments, particularly in the field of heart failure
- Glyco-sulfo hotspots in the chemokine receptor system
C et al. 2013) for O-glycosylation and the sulfinator tool for tyrosine sulfation sites (Monigatti F
- The complicated lives of GPCRs in cardiac fibroblasts
October 2022 "The role of different G protein-coupled receptors (GPCRs) in the cardiovascular system is well understood in cardiomyocytes and vascular smooth muscle cells (VSMCs). In the former, stimulation of Gs-coupled receptors leads to increases in contractility, whereas stimulation of Gq-coupled receptors modulates cellular survival and hypertrophic responses. In VSMCs, stimulation of GPCRs also modulates contractile and cell growth phenotypes. Here, we will focus on the relatively less well-studied effects of GPCRs in cardiac fibroblasts, focusing on key signaling events involved in the activation and differentiation of these cells. We also review the hierarchy of signaling events driving the fibrotic response and the communications between fibroblasts and other cells in the heart. We discuss how such events may be distinct depending on where the GPCRs and their associated signaling machinery are localized in these cells with an emphasis on nuclear membrane-localized receptors. Finally, we explore what such connections between the cell surface and nuclear GPCR signaling might mean for cardiac fibrosis." Read more at the source #DrGPCR #GPCR #IndustryNews